According to Gan et al. [48], the circRNA-101237/let-7a-5p/IGF2BP3 axis, which plays a role in controlling cardiomyocyte death, presents potential as a promising therapeutic target for addressing cardiovascular diseases, including MI. This evidence concerns the gene IGF2BP3 and cardiovascular disorder.